IT201900020646A1 - EXTRACT OF NIGELLA SATIVA INCLUDING TIMOQUINONE AND NIGELLAMINS, PROCESS FOR ITS PREPARATION AND COMPOSITIONS THAT CONTAIN IT USEFUL FOR THE REDUCTION OF THE FIRMICUTES / BACTEROIDETES RATIO IN THE INTESTINAL MICROBIOTA - Google Patents

EXTRACT OF NIGELLA SATIVA INCLUDING TIMOQUINONE AND NIGELLAMINS, PROCESS FOR ITS PREPARATION AND COMPOSITIONS THAT CONTAIN IT USEFUL FOR THE REDUCTION OF THE FIRMICUTES / BACTEROIDETES RATIO IN THE INTESTINAL MICROBIOTA

Info

Publication number
IT201900020646A1
IT201900020646A1 IT102019000020646A IT201900020646A IT201900020646A1 IT 201900020646 A1 IT201900020646 A1 IT 201900020646A1 IT 102019000020646 A IT102019000020646 A IT 102019000020646A IT 201900020646 A IT201900020646 A IT 201900020646A IT 201900020646 A1 IT201900020646 A1 IT 201900020646A1
Authority
IT
Italy
Prior art keywords
timoquinone
nigellamins
firmicutes
extract
compositions
Prior art date
Application number
IT102019000020646A
Other languages
Italian (it)
Inventor
Pierro Francesco Di
Original Assignee
Velleja Res S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Velleja Res S R L filed Critical Velleja Res S R L
Priority to IT102019000020646A priority Critical patent/IT201900020646A1/en
Publication of IT201900020646A1 publication Critical patent/IT201900020646A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
IT102019000020646A 2019-11-08 2019-11-08 EXTRACT OF NIGELLA SATIVA INCLUDING TIMOQUINONE AND NIGELLAMINS, PROCESS FOR ITS PREPARATION AND COMPOSITIONS THAT CONTAIN IT USEFUL FOR THE REDUCTION OF THE FIRMICUTES / BACTEROIDETES RATIO IN THE INTESTINAL MICROBIOTA IT201900020646A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102019000020646A IT201900020646A1 (en) 2019-11-08 2019-11-08 EXTRACT OF NIGELLA SATIVA INCLUDING TIMOQUINONE AND NIGELLAMINS, PROCESS FOR ITS PREPARATION AND COMPOSITIONS THAT CONTAIN IT USEFUL FOR THE REDUCTION OF THE FIRMICUTES / BACTEROIDETES RATIO IN THE INTESTINAL MICROBIOTA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102019000020646A IT201900020646A1 (en) 2019-11-08 2019-11-08 EXTRACT OF NIGELLA SATIVA INCLUDING TIMOQUINONE AND NIGELLAMINS, PROCESS FOR ITS PREPARATION AND COMPOSITIONS THAT CONTAIN IT USEFUL FOR THE REDUCTION OF THE FIRMICUTES / BACTEROIDETES RATIO IN THE INTESTINAL MICROBIOTA

Publications (1)

Publication Number Publication Date
IT201900020646A1 true IT201900020646A1 (en) 2021-05-08

Family

ID=69903811

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102019000020646A IT201900020646A1 (en) 2019-11-08 2019-11-08 EXTRACT OF NIGELLA SATIVA INCLUDING TIMOQUINONE AND NIGELLAMINS, PROCESS FOR ITS PREPARATION AND COMPOSITIONS THAT CONTAIN IT USEFUL FOR THE REDUCTION OF THE FIRMICUTES / BACTEROIDETES RATIO IN THE INTESTINAL MICROBIOTA

Country Status (1)

Country Link
IT (1) IT201900020646A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190008907A1 (en) * 2017-07-07 2019-01-10 Noori AL-WAILI Compositions for management of wounds, skin diseases, dehydration, chronic diseases, and respiratory diseases
WO2019016794A1 (en) * 2017-07-15 2019-01-24 Trinutra Ltd. Compositions comprising thymoquinone and omega-3 fatty acids

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190008907A1 (en) * 2017-07-07 2019-01-10 Noori AL-WAILI Compositions for management of wounds, skin diseases, dehydration, chronic diseases, and respiratory diseases
WO2019016794A1 (en) * 2017-07-15 2019-01-24 Trinutra Ltd. Compositions comprising thymoquinone and omega-3 fatty acids

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ABDOL-SAMAD ABEDI ET AL: "Microencapsulation of Nigella sativa seeds oil containing thymoquinone by spray-drying for functional yogurt production", INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY., vol. 51, no. 10, 31 July 2016 (2016-07-31), GB, pages 2280 - 2289, XP055710131, ISSN: 0950-5423, DOI: 10.1111/ijfs.13208 *
CHEM PHARM ET AL: "Communications to the Editor Pharmaceutical Society of Japan New Dolabellane-Type Diterpene Alkaloids, with Lipid Metabolism-Promoting Activities from the Egyptian Medicinal Food Black Cumin", BULL, 1 January 2004 (2004-01-01), XP055709984, Retrieved from the Internet <URL:https://www.jstage.jst.go.jp/article/cpb/52/4/52_4_494/_pdf/-char/en> *
GOYAL SN ET AL.: "Therapeutic potential and pharmaceutical Development of Thymoquinone: A multicharged molecule of Natural Origin", FRONT PHARMACOL., vol. 8, 21 September 2017 (2017-09-21), pages 656
IJAZ H ET AL.: "Nigella sativa (Prophetic Medicine", PAK J PHARM SCI., vol. 30, no. l, January 2017 (2017-01-01), pages 229 - 234
LEY RE ET AL.: "Microbial echology: human gut microbes associated with obesity", NATURE, vol. 444, no. 7122, 2006, pages 1022 - 3
MORIKAWA T ET AL.: "Nigellamines A3, A4, A5, and C, new dolabellane-type diterpene alkaloids, with lipid metabolism-promoting activities from the Egyptian medicinal food black cumin", CHEM PHARM BULL (TOKYO, vol. 52, no. 4, April 2004 (2004-04-01), pages 494 - 7
TURNBAUGH PJ ET AL.: "An obesity-associated gut microbiome with increased capacity for energy harvest", NATURE, vol. 444, no. 7122, 2006, pages 1027 - 31, XP002510854, DOI: 10.1038/nature05414

Similar Documents

Publication Publication Date Title
MA50175A (en) HIGH-DOSAGE VALBENAZINE FORMULATION AND RELATED COMPOSITIONS, METHODS AND KITS
WO2017100726A8 (en) Methods for treating huntington&#39;s disease
WO2014160441A8 (en) Neuroactive steroids, compositions, and uses thereof
AR108800A1 (en) PURIFICATION OF MULTI-SPECIFIC ANTIBODIES
AR107781A1 (en) BISPECIFIC MOLECULES THAT HAVE IMMUNORREACTIVITY WITH PD-1 AND CTLA-4, AND METHODS OF USE OF THE SAME
EP3892316A3 (en) Cell separation devices, systems, and methods
CL2020000632A1 (en) Composition and method for the treatment of autism.
EA201791702A1 (en) THERAPEUTIC TOOLS ON THE BASIS OF GLYCANS AND RELATED METHODS
IL257358B (en) Methods and pharmaceutical compositions for improving wound healing using cd24
CU24498B1 (en) FACTOR XI ANTIBODIES
HK1256414A1 (en) Novel carbohydrate antibodies, pharmaceutical compositions and uses thereof
EP3310719A4 (en) Compositions and methods for analytical sample preparation
BR112018071026A2 (en) photoactive macromolecules and uses thereof
WO2015166492A3 (en) Microbiome response to agents
BR112019003987A2 (en) cenicriviroc mesylate solid forms and production processes of cenicriviroc mesylate solid forms
EP2642326A3 (en) Automatic calibration of a microscope scanning system
EP3991724A3 (en) Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof
WO2015136370A3 (en) Sterilization and filtration of peptide compositions
BR112017007393A2 (en) anti-il-7r antibody compositions
CL2016001937A1 (en) Functionalized benzopyran compounds and their use
EP3521826A4 (en) Method, composition, and chip for detecting analysis object in blood sample
EP3586872A4 (en) Pharmaceutical composition, antigen-binding molecules, treatment method, and screening method
EP3409709A4 (en) Photocuring method, compound and composition used therein
FI20155076A (en) Method and Apparatus for Increasing the Concentration of a Soluble Carbohydrate Fraction, a Soluble Carbohydrate Containing Fraction, a Solid Fraction, and Their Use
IT201700025666A1 (en) Composition for use in the treatment of hypercholesterolemia and in the prevention of cardiovascular diseases.